A second X chromosome contributes to resilience in a mouse model of Alzheimer’s disease
Emily Jane Davis(University of California, San Francisco), Dena B. Dubal(University of California, San Francisco), Lauren Broestl(University of California, San Francisco), David A. Bennett(Rush University Medical Center), Julie A. Harris(Allen Institute), Samira Abdulai-Saiku(University of California, San Francisco), Kurtresha Worden(University of California, San Francisco), Arturo J. Moreno(University of California, San Francisco), Cliff Anderson-Bergman(Gladstone Institutes), Bruce L. Miller(University of California, San Francisco), Barbara Panning(University of California, San Francisco), Arthur P. Arnold(UCLA Health), Luke W. Bonham(University of California, San Francisco), Gina Williams(University of California, San Francisco), Bayardo I. Garay(Gladstone Institutes), Jennifer S. Yokoyama(University of California, San Francisco), Kevin Chang(University of California, San Francisco), Lennart Mucke(Gladstone Institutes), Nino Devidze(Gladstone Institutes), Jorge J. Palop(Gladstone Institutes), Daniel Kim(Gladstone Institutes), Dan Wang(Wuhan Polytechnic University), Gui-Qiu Yu(Gladstone Institutes), Charles C. White(Broad Institute), Iryna Lobach(University of California, San Francisco), Phil L. De Jager(Columbia University), Elena Miñones-Moyano(University of California, San Francisco)
Cited by 186
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|7.1k
A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers
|Neurology|2016|1.9k